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r the Study of the Liver. Published bSummary Background: Many tumors are small and located around the gastrointestinal (GI)
tract, and they are difficult to obtain tissue from for pathological diagnosis by the guidance
of conventional methods (sonography or computed tomography. The aim of this study was to
analyze the efficacy and benefit of endoscopic ultrasound-guided fine needle aspiration
(EUS-FNA) in the clinical diagnosis of solid tumors in the mediastinum and abdomen.
Patients and methods: Data from 233 patients with solid tumors on or around the GI tract were
reviewed. They had received successful EUS-FNA without on-site cytopathology study.
Results: The lesions were classified according to the anatomic location as pancreatic tumors
(Group A, nZ 91), mediastinal tumors (including lymph nodes) (Group B, nZ 38), abdominal
tumors (including lymph nodes) (Group C, nZ 49), focal transmural thickening of the GI tract
(Group D, nZ 6), and submucosal tumors of the GI tract (Group E, nZ 49). The accuracies of
pathological diagnosis of malignancy were 79.2%, 76.9%, 93.2%, and 80% for Groups AeD,
respectively. The overall accuracy for malignancy was 82.9%. For the submucosal tumors of
the GI tract in Group E, FNA cytopathology provided evidence of specific diagnosis all were
GI stromal tumor in 47% of the cases, 14% were diagnosed as suspicious (most were of a spindle
cell tumor nature), and 39% were considered negative of tumor or non-diagnostic. There were
three episodes (1.3%) of complication (GI bleeding, n Z 1; septic fever, n Z 1; gallbladder
puncture, nZ 1) which occurred among all patients in this study, and all of them were treated
appropriately, with no occurrence of life-threatening events.Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Number
ichung 40705, Taiwan.
(H.-Z. Yeh).
5.01.003
roenterological Society of Taiwan, The Digestive Endoscopy Society of Taiwan and Taiwan Association
y Elsevier Taiwan LLC.Open access under CC BY-NC-ND license.
62 S.-S. Yang et al.Conclusion: EUS-FNA appears to be a very useful tool for obtaining tissue diagnosis for lesions
that are inaccessible by the conventional methods and was shown to be a safe and effective
technique in the hands of experienced operators. Pathological diagnosis can be obtained for
the guidance of clinical management to avoid the more invasive ways, such as surgery or medi-
astinal scope.
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Clinically, many tumor lesions are located on or around the
gastrointestinal (GI) wall. Standard transabdominal ultra-
sound and computed tomography (CT) are used to guide
fine-needle aspiration (FNA) for the purpose of pathological
diagnosis or tumor staging [1,2]. Ultrasound guidance is
usually preferred over CT because ionizing radiation is
avoided and the needle is visualized in real-time, but there
are several disadvantages including difficulty in visualizing
the needle tip clearly and consistently, presence of over-
lying bowel gas, and inability to delineate intervening tis-
sues [3,4]. Furthermore, many of these lesions are often
too small to be properly detected and evaluated by con-
ventional sonography or a CT scan [5].
Endoscopic ultrasound (EUS) is now widely applied for the
visualization of the GI wall and the surrounding structures,
and for the staging of GI tumors [6,7]. Linear scanning ul-
trasonography allows for close tracking of a needle as it is
advanced into the ultrasound plane and thus this technology
has led to the development of EUS-guided FNA (EUS-FNA)
biopsy. Vilmann et al [8] reported the first case of FNA
cytology andGrimmet al [9] treated a casewith a pseudocyst
by EUS-FNA in 1992. Since then, EUS-FNA has become more
popular in the clinical diagnosis, especially in the Western
world. According to the literature, the accuracy of EUS-FNA
has been 70e100% in mediastinal or intra-abdominal tumors
and was relatively lower (38e100%) in GI wall lesions such as
submucosal tumors [10e15]. However, this modality has still
not been so widely applied in Asian countries, because it is
technically challenging [11]. Another barrier to more wide-
spread adoption of EUS-FNA is the small size of aspirated
specimens it can provide due to the small caliber of the
needle. Making the correct cytopathological diagnosis with a
EUS-FNA specimen remains a challenge [16e18].
The purpose of the present study was to assess the ef-
ficacy and safety of EUS-FNA for clinical diagnosis of solid
tumors in the mediastinum and abdomen.
Patients and methods
Patient selection
From January 2005 to December 2012, 268 patients with
tumor lesions received EUS-FNA for clinical diagnosis in this
hospital. Patients were recruited into this study if they
fulfilled the following conditions: (1) a tumor lesion on the
wall of the GI tract that could not be accurately diagnosed
by endoscopic biopsy; and (2) a tumor lesion around the GItract that was difficult to access by conventional ultraso-
nography or CT scan. The exclusion criteria for EUS-FNA
were: (1) patients who declined to undergo the procedure;
(2) evidence of coagulopathy, or lesion could not be punc-
tured safely with the needle under linear array endo-
sonography; (3) patients underwent EUS-FNA for cystic
lesions (cystic space > 25% of the lesion); and (4) patients
under EUS-FNA for the inclusion criteria but the final
outcome cannot be verified.
EUS-FNA
An Olympus EU-C2000 EUS center and a linear scanning ul-
trasound transducer UC2000P (Olympus, Tokyo, Japan) were
used for image observation and puncture guidance. A 22-
gauge needle including NA-11J-KB/EZ shot (Olympus) and
EUSN-1 (Cook Medical, Winston-Salem, NC, USA) was used in
all of the puncture procedures. All patients provided
informed consent prior to examination. Routine premed-
ication for endoscopy was conducted with intramuscular
injections of buscopan (20 mg) and pethidine 25e50 mg,
followed by pharyngeal anesthesia. Intravenous injection of
midazolam 3 mg was given when required for mild sedation
(rarely needed in this study). The lesions were scanned with
EUS to determine the proper route of puncture. Power
Doppler ultrasonography was used to avoid injury to vessels.
When it was confirmed in the EUS image that the needle
had been properly inserted into the lesion, the stylet of the
needle was removed and the needle was connected to a
syringe with a negative pressure (0w10 mL). The needle
was then moved back and forth > 10 times to obtain a
tissue specimen (Fig. 1). After withdrawing the needle, the
target lesion was observed by EUS to determine whether
any changes (shape or internal texture) occurred in the
tumor. The adjacent tissue was also carefully observed to
determine whether there were any changes, such as he-
matoma. Because on-site cytopathologic evaluation was
not available in our hospital, the needle punctures were
repeated several times (2w5 times puncture when
possible) until there was gross evidence that tissue parti-
cles had been obtained, or the maximal number of punc-
tures had been performed. At the end of the procedures,
absence of bleeding at the point of puncture was confirmed
endoscopically. Aspirates were prepared on glass slides and
fixed in absolute alcohol solution for the cytological study.
When sufficient materials had been obtained, the speci-
mens were also put in the formalin solution for pathological
evaluation (hematoxylin-eosin staining and other immuno-
histochemical stains as necessary).
Figure 1 A patient with pancreatic head neuroendocrine tumor and mediastinal lymph node metastasis diagnosed by endoscopic
ultrasound-guided fine needle aspiration (EUS-FNA) cytopathology. (A) The EUS image of the mediastinal lymph node by radial
echoprobe and (B) the EUS image of the performance of EUS-FNA.
Table 1 Clinical characteristics of patients who received
endoscopic ultrasound-guided fine needle aspiration (EUS-
FNA) in this study.
Clinical characteristics No. (%)
Age (y) 34w82 (mean: 67  14.5)
Sex
Male 135 (57.9)
Female 98 (42.1)
Tumor size (cm)a 1w7 (mean: 3.2  2.8)
Tumor location
Pancreas (Group A) 91 (39.1)
Head 41 (45.1)
Body/tail 45 (49.5)
Diffuse enlargement 5 (5.4)
Mediastinum (Group B) 38 (16.3)
Intra-abdomen (Group C) 49 (21.0)
Transmural wall
thickening (Group D)
6 (2.6)
Submucosal tumor (Group E) 49 (21.0)
Needle puncture No. 2e5 (mean: 2.6  2.1)
a Not including the diffuse enlargement of pancreatic tumors
and the transmural gastrointestinal (GI) lesions.
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The final diagnosis of malignancy was verified if any of the
aspiration/biopsy for the lesion revealed a definite diag-
nosis of malignancy. If negative results of malignancy were
noted from the procedure, the diagnosis were the surgical
pathology if a surgery was performed. When a cytopatho-
logical diagnosis was not obtained, a diagnosis of malig-
nancy was still made if the physicians who were taking care
of the patient were confident of the clinical diagnosis of
malignancy (usually by images). The negative malignancy
state was verified by long-term clinical follow up. A nega-
tive malignancy state without surgical pathology was
defined as no prominent progression (< 25% size) of the
target lesion after a 1-year follow-up duration. The results
of the procedure were compared with the final diagnosis to
evaluate the accuracy of this procedure. The safety profile,
including minor and major complications, was also analyzed
and reported. The diagnostic yield including sensitivity,
specificity, positive predictive value (PPV), negative pre-
dictive value (NPV), and accuracy were calculated for EUS-
FNA by comparing the results of these techniques with the
final diagnosis.
Ethical approval
This study was approved by the Ethics Committee of our
hospital. Written consent was obtained from each patient
or a relative.
Results
Among the 268 patients, 233 patients with successful FNA
procedures for solid tumors (98 women, 135 men) with
verified clinical outcome for review were included in this
study. These patients were classified according to the
anatomic location of the lesions as pancreatic tumors
(Group A, n Z 91), mediastinal tumors (including lymph
node) (Group B, n Z 38), abdominal tumorous lesions
(including lymph node) (Group C, nZ 49), focal transmural
thickening of the GI tract (Group D, n Z 6, all were withnonspecific diagnosis from endoscopic biopsy), submucosal
tumors of the GI tract (Group E, n Z 49) (Table 1; Fig. 2).
The accuracies of pathological diagnosis of malignancy
were 79.2%, 76.9%, 93.2%, and 80% for groups AeD,
respectively. The respective sensitivity, specificity, PPV,
NPV are also shown (Table 2). The respective proportion of
the pancreatic tumors according to the different locations
and their diagnostic accuracies are shown in Fig. 3. In total,
for all of these lesions, the overall accuracy for the diag-
nosis of malignancy was 82.9%. For the stromal tumors of
the GI tract in Group E (all originating from below the
submucosal layer), FNA cytopathology showed evidence of
specific diagnosis of GIST in all (47%) of these cases, 14%
were diagnosed as suspicious (most were of a spindle cell
Figure 2 Patient recruitment and classification according to anatomical characteristics of the lesions.
Table 2 The sensitivity, specificity, positive predictive value (PPV), negative PV (NPV), and diagnostic accuracies of malig-
nancy by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in different patient groups (Groups AeD).
Group Lesion location No. of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
A Pancreas 91 80.5 100 100 48.3 79.2
B Mediastinum 38 73.1 91.7 95 61.1 76.9
C Intra-abdomen 49 90.9 80.0 97.6 50 93.2
Dy GI ethickening (transmural) 6 80 100 100 50 80.0
All 184 82.2 93.8 98.4 52.6 82.9
NPV Z negative predictive value; PPV Z positive predictive value; TCVGH Z Taichung Veterans General Hospital; LN Z lymph node.
64 S.-S. Yang et al.tumor nature, except for one adenocarcinoma) and 39%
were considered negative for tumor or non-diagnostic. For
the patients with negative or non-diagnostic FNA cytopa-
thology, none were found to have an outcome ofFigure 3 Number, proportion, and diagnostic accuracies of
endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)
for the pancreatic tumor according to the different tumor
locations.malignancy progression or tumor-related morbidity/mor-
tality (Fig. 3).
About two thirds of these cases received FNA at the
outpatient clinic. These patients recovered from the light
sedation shortly after the procedure and were discharged
without complication. There were three episodes of
complication (UGI bleeding, n Z 1; septic fever, n Z 1;
gallbladder puncture, n Z 1) among all patients (1.3%) in
this study. The gallbladder puncture was related to the
incorrect interpretation of an EUS image for a paragastric
GIST due to echoprobe dysfunction, and cholecystectomy
was performed during the elective gastrectomy. The case
of UGI bleeding was related to incidental puncture of a
gastric wall vessel and such events are rare. The case of
septic fever may be due to a tumor necrosis effect after
repeated punctures (no bacteremia was found through the
course). All of these three patients recovered uneventfully
after appropriate treatment.
Discussion
The study results show that the yield of punctures differed
according to the lesions with location of the puncture and
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from the aspiration of enlarged lymph nodes or tumors from
the intra-abdominal region. Pancreatic tumors constituted
the largest proportion of the targets of EUS-FNA because
most suspected pancreatic malignancies were out of the
range of surgical resection. Tissue diagnosis is thus impor-
tant for further management. The accuracy of EUS-FNA for
pancreatic tumors overall was 79.2%. The accuracy was
better for tumors over the body or tail of the pancreas
(82.9%), but was relatively lower (75%) for tumors on the
pancreatic head, especially the uncinate process. The
relatively low yield rate may have been due to necrosis
inside the tumor and technical difficulty on this area. Per-
forming puncture for the pancreatic head lesions, espe-
cially the uncinate process, was the most difficult, because
a certain amount of bending and twisting of the echoen-
doscope is needed to correctly position the instrument for
puncture and this brings considerable resistance for the
needle to extrude from the sheath. The pushing force,
thus, cannot be transmitted to the needle from the prox-
imal handle [11]. In some cases, collateral vessels were
seen around the pancreatic head due to the compression or
invasion of the tumor and this hindered the access of the
needle. In fact, three of five patients with EUS-FNA failure
had pancreatic head lesions.
The accuracy of EUS-FNA for the abdominal tumors other
than the pancreas was 93.2%, and this high yield rate was
highly related to the low necrotic nature of the lymph node
as well as the tissue characteristics. Technically, the
puncture of the mediastinal lymph node was the easiest,
because it is usually possible to maintain the echoprobe in a
relatively straight position [19]. However, the accuracy for
the mediastinal lesion was lower than that for abdominal
lesions, which may have been due to the relatively smaller
tumor size and the higher risk associated with the puncture
over this location.
Most of the mural lesions were submucosal tumors
originating from below the submucosal layer. For the le-
sions which received FNA in our hospital, the size was
usually intermediate (2w4 cm in diameter). For tumors > 4
cm, needle puncture was not usually necessary, because
surgical resections were always the first option unless there
were unresectable, or a poor surgical condition was
considered. For tumors < 2 cm, malignant behavior is un-
usual and so endoscopic follow-up was typically suggested.
For those submucosal tumors which received FNA, a diag-
nostic yield of 61% was attained if samples with spindle cell
cytology were included. Only 47% of lesions could be given a
more precise pathologic diagnosis (all were GIST). However,
evaluation of the malignant potential, such as mitotic fig-
ures, is still difficult due to the small size of the specimens.
This phenomenon in the present study is comparable with
the results of previous studies [16]. The difficulty of per-
forming puncture for submucosal tumors depends on the
size of the tumor and also on the location. If the tumor was
> 3 cm, the puncture was not too difficult irrespective of
the location. However, for a smaller tumor, location over
the fundus and the lesser curvature side of the antrum
result in a relatively difficult puncture, because the echo-
scope must be placed in a tortuous position.
Another possible cause of the relatively low yield of
submucosal tumor subjected to aspiration was the natureof the fibrous stroma [17]. The aspiration content in our
study was usually low despite our best efforts. There is still
much room left for improvement of aspiration from sub-
mucosal tumors. The usage of larger bore puncture needles
or the Tru-cut needle may help to acquire a greater volume
of specimens, although its application may be more difficult
compared with the use of a conventional small bore needle
[20]. The application of a special immunohistochemical
stain may also improve the diagnostic rate for specimens
with a small volume [21]. The application of FNA for sub-
mucosal tumors provides other advantages. Dig-in biopsy or
strip biopsy were also used to obtain tissue from submu-
cosal tumors. However, this may create a large mucosal
defect on the tumor and recurrent tumor bleeding may
occur.
There were several cases (1.9%) for which successful
puncture of the target lesion could not be accomplished
when we attempted to perform FNA. In most of these cases,
the lesions were small and located on the pancreatic neck
or uncinate process, requiring considerable bending of the
echoscope to orient the needle, and this caused great
friction between the needle and its outer sheath. Con-
cerning the safety of the procedure, puncture performed
with a 22G fine needle for a solid mass lesion is generally
considered to be safe, because significant complications
are rare. Three complications (1.3%) in all puncture cases
occurred in this study. The complications of these three
patients improved after medical or surgical treatment.
However, complications such as bleeding may still occur if
the needle punctures a large vessel [22]. A clear visuali-
zation of the needle on the sonographic scanning is very
important, especially in the mediastinum, due to the close
proximity of the mediastinal large vessels.
With the help of curvilinear electronic echoendoscopy,
the puncture needle can be visualized clearly in most sit-
uations. Therefore, EUS provides a safe and reliable mo-
dality for obtaining pathological specimens [23,24].
However, the puncture needle should be visualized clearly
on sonographic monitoring. If visualization of the needle
becomes compromised, the puncture should not proceed
unless the needle can be redirected in the appropriate
orientation.
Clinical benefits are evident if a malignant state can be
proved by the FNA procedure, because tissue diagnosis is
often crucial for the clinical decision. Further treatment
planning may include surgery, chemotherapy, or just hos-
pice care can be proceeded. Thus, patients can be spared
from a more invasive way such as surgery or mediastinal
scope for tissue diagnosis. There was no on-site cytopa-
thologic evaluation in this study. The adequacy of FNA
specimens can be judged grossly by the appearance of tis-
sue fragments or tissue particles evident on the smear. If
the specimens were bloody, gross interpretation of ade-
quacy was difficult, so on-site cytopathology would be
helpful as it would obviate the need for additional punc-
ture. However, on-site cytopathology is not always
available.
In summary, EUS-FNA was demonstrated to be a very
useful tool for performing tissue diagnosis of lesions that
are inaccessible by conventional methods. The technique
was shown to be extremely safe and was effective in the
hands of experienced operators, even without on-site
66 S.-S. Yang et al.cytopathology. The accuracy of this diagnostic tool depends
on the experience of the operator performing the puncture
technique, appropriate tumor position, and the tumor
pathology.
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